Younkin SG - Search Results

1

Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy.

Greenberg SM, Cho HS, O'Donnell HC, Rosand J, Segal AZ, Younkin LH, Younkin SG, Rebeck GW. Greenberg SM, et al. Among authors: younkin lh, younkin sg. Ann N Y Acad Sci. 2000 Apr;903:144-9. doi: 10.1111/j.1749-6632.2000.tb06361.x. Ann N Y Acad Sci. 2000. PMID: 10818500

2

Serum creatinine levels correlate with plasma amyloid Beta protein.

Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR. Arvanitakis Z, et al. Among authors: younkin lh, younkin sg. Alzheimer Dis Assoc Disord. 2002 Jul-Sep;16(3):187-90. doi: 10.1097/00002093-200207000-00009. Alzheimer Dis Assoc Disord. 2002. PMID: 12218650

3

Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG. Golde TE, et al. Among authors: younkin lh, younkin sg. Science. 1992 Feb 7;255(5045):728-30. doi: 10.1126/science.1738847. Science. 1992. PMID: 1738847

4

In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease.

Cohen ML, Golde TE, Usiak MF, Younkin LH, Younkin SG. Cohen ML, et al. Among authors: younkin lh, younkin sg. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1227-31. doi: 10.1073/pnas.85.4.1227. Proc Natl Acad Sci U S A. 1988. PMID: 3277188 Free PMC article.

5

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, Younkin SG. Gravina SA, et al. Among authors: younkin lh, younkin sg. J Biol Chem. 1995 Mar 31;270(13):7013-6. doi: 10.1074/jbc.270.13.7013. J Biol Chem. 1995. PMID: 7706234 Free article.

6

Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease.

Nakamura T, Shoji M, Harigaya Y, Watanabe M, Hosoda K, Cheung TT, Shaffer LM, Golde TE, Younkin LH, Younkin SG, et al. Nakamura T, et al. Among authors: younkin lh, younkin sg. Ann Neurol. 1994 Dec;36(6):903-11. doi: 10.1002/ana.410360616. Ann Neurol. 1994. PMID: 7998778

7

Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.

Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM. Fagan AM, et al. Among authors: younkin lh, younkin sg. Ann Neurol. 2000 Aug;48(2):201-10. Ann Neurol. 2000. PMID: 10939571

8

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Kawarabayashi T, et al. Among authors: younkin lh, younkin sg. J Neurosci. 2001 Jan 15;21(2):372-81. doi: 10.1523/JNEUROSCI.21-02-00372.2001. J Neurosci. 2001. PMID: 11160418 Free PMC article.

9

Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.

Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Adamson J, Schaid DJ, Blangero J, Hutton M, Younkin SG. Ertekin-Taner N, et al. Among authors: younkin lh, younkin sg. Genet Epidemiol. 2001 Jul;21(1):19-30. doi: 10.1002/gepi.1015. Genet Epidemiol. 2001. PMID: 11443731

10

Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.

Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE. Das P, et al. Among authors: younkin lh, younkin sg. Neurobiol Aging. 2001 Sep-Oct;22(5):721-7. doi: 10.1016/s0197-4580(01)00245-7. Neurobiol Aging. 2001. PMID: 11705631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters